Variant · Snv
TNPO3 NM_012470.4(TNPO3):c.2062-12T>G
CI-VAR-00047262Explore in graph →NM_012470.4:c.2062-12T>GClinVar 260261 rs112438598
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 260261 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Autosomal dominant limb-girdle muscular dystrophy type 1F; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Uveal melanoma; Familial pancreatic carcinoma; Sarcoma; Lymphoma; Acute myeloid leukemia; Malignant tumor of esophagus; Nonpapillary renal cell carcinoma; Lung cancer; Ovarian cancer; Uterine corpus endometrial carcinoma; Gastric cancer; Ovarian serous cystadenocarcinoma | germline | 5 | Feb 03, 2026 | clinvar |